Eukles Asset Management
- SEC CIK
- 0001632553
- Latest filing
- Aug 5, 2026
EW holding history
Edwards Lifesciences Corp in every 13F filed by Eukles Asset Management, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EW overviewAll 13F holders of EWFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −125−100.0% | Sold out | Holders |
| Q4 2023 | 125 | $9.53K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 125 | $8.66K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 125 | $11.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 125 | $10.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 125 | $9.00K | <0.1% | +125 | New | Holders |